🇺🇸 FDA
Patent

US 11242377

Chimeric receptor with ligand binding exodomain and cytokine and T cell signalling endodomains

granted A61KA61K2039/54A61K2039/572

Quick answer

US patent 11242377 (Chimeric receptor with ligand binding exodomain and cytokine and T cell signalling endodomains) held by AUTOLUS LIMITED expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AUTOLUS LIMITED
Grant date
Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K2039/54, A61K2039/572, A61K2239/13, A61K2239/17